Impact of L-Arginine and L-Glutamine supplementation on growth performance and immune status in weanling pigs challenged with Escherichia coli F4.

Arginine (ARG) and Glutamine (GLN) have been reported to play significant roles in protein metabolism, immunity, and intestinal health in weanling pigs. The present study investigated the independent and interactive effect of supplementing ARG and GLN on pigs immune status and growth performance following an Escherichia coli F4 challenge. A total of 240 mixed-sex pigs (24 ±â€…2 d old; 7.3 ±â€…0.1 kg BW) were used in a 42-d experiment after selection for E. coli F4 susceptibility. The pigs were group-housed (3 pigs per pen), and pens were randomly assigned to five experimental treatments (N = 16 pens per treatment). Experimental treatments were: 1) a wheat-barley-soybean meal-based basal diet (CTRL), 2) a basal diet with 2500 mg/kg zinc oxide (ZnO), 3) a basal diet + 0.5% Glutamine (0.5% GLN), 4) basal diet + 0.5% Arginine (0.5% ARG), and 5) basal diet with 0.5% Glutamine + 0.5% Arginine (0.5% GLN + ARG). All Pigs were inoculated with E. coli F4 on days 7, 8, and 9 post-weaning. Rectal swabs were taken from each pig and plated on blood agar plates for E. coli F4 presence. Blood and fecal samples were taken to determine the acute phase response and selected fecal biomarkers for the immune response. Growth performance and fecal scores were recorded. Fecal swabs resulted in no positive pig for E. coli F4 before inoculation and 73.3% positive postinoculation. Diarrhea incidence during days 7 to 14 was significantly lower for the ZnO treatment (P < 0.05). The haptoglobin level on day 3 was lower than days 10 and 20, irrespective of treatment (P < 0.05). The albumin level was lower on day 20 compared to days 3 and 10 (P < 0.05). There was no treatment effect on albumin levels regardless of sampling day (P > 0.05). The PigMAP was lowest on day 3 and highest on day 10 (P < 0.05). We did not observe significant treatment differences (P > 0.05) in myeloperoxidase and calprotectin. Pancreatitis-associated protein was higher in the ZnO (P = 0.001) treatment than in the other treatments. Fecal IgA tended (P = 0.10) to be higher in the ZnO and 0.5% ARG treatments. There were no performance differences, except during days 0 to 7, where the ZnO treatment was lower in average daily gain and average daily feed intake (P < 0.001), while feed efficiency (G:F) FE was similar across treatments. In summary, no improved performance was observed with either ARG, glutamate, or both. The immune response results showed that the E. coli F4 challenge may have exacerbated the acute phase response; hence, the benefits of dietary treatments did not go beyond immune repair and reduction in inflammation.

The supplementation of functional amino acids such as arginine and glutamine has been reported to improve growth performance in weanling pigs. However, during periods of enteric Escherichia coli challenge, results have been inconsistent. Here, we investigated whether independent or combined arginine and glutamine supplementation could improve performance and immune response under an E. coli F4 challenge. The results showed no performance improvements but an improvement in the acute phase response and immune response status. Thus, the benefit of supplemental arginine and glutamine may be prioritized towards building an immune response rather than growth under conditions of an enteric immune challenge.

The effect of supplementation of essential amino acid combinations in a low crude protein diet on growth performance in weanling pigs.

The present study investigated the impact of providing different supplemental essential amino acids (EAA) in a low crude protein (CP) diet on growth performance in weanling pigs. A total of 324 mixed-sex 24-d weaned piglets (initial BW 6.9 ± 0.34 kg) were used in a 27-d growth trial with six dietary treatments immediately post-weaning. The first two treatments were a control standard CP (19%) diet (positive control; PC) and a negative control (NC) diet with low CP (16%) and reduced Ile, Leu, and histidine levels. The rest of the treatments had low CP with varied EAA types and levels; T1 had similar Ile, Leu, and His levels as PC but with low CP (16%), while T2 had low CP and 10% higher His, Thr, Trp, and Met+Cys compared to PC. The T3 was a low CP diet with 10% supplemental Leu, Ile, and Val compared to PC, while T4 was a low CP diet with 10% supplementation with all the EAA except Lys compared to PC. The initial body weight (BW) was not statistically different (P > 0.05) among the treatments. Also, on d 6, no statistical differences in BW were observed among the treatments. The average BW recorded on d 13, 20, and 27 showed significant treatment differences where the PC had consistently higher BW than all the other treatments (P < 0.05). The average daily gain (ADG) of the PC was higher than the rest of the treatments. Between d 13 and 20, the average daily feed intake (ADFI) for PC was not different from NC and T1 (P > 0.05), but compared to T2, T3, and T4, the PC treatment showed a high ADFI (P < 0.05). Overall (d 0-27), the ADFI for PC was not different from T1 and was significantly higher than all other treatments. Overall, results showed that the gain to feed (G:F) ratio was higher (P < 0.05) for PC compared to other dietary treatments. In summary, although the treatments (T1-T4) consisted of varying levels of EAA above the recommended requirement levels for optimal performance, we did not see a significant impact on growth performance improvement, which may indicate that the targeted EAA (His, Val, Thr, lle, Leu, Trp, and Met) may not have been limiting in these diets. On the other hand, the phenylalanine (Phe) requirement may be limited in the current formulations, or perhaps the EAA: total N ratio in T1, T2, T3, and T4 may have been too high, resulting in the inefficiency of EAA utilization for growth.

Effect of Fiber Fermentation and Protein Digestion Kinetics on Mineral Digestion in Pigs.

Nutrient kinetic data and the timing of nutrient release along the gastrointestinal tract (GIT), are not yet widely used in current feed formulations for pigs and poultry. The present review focuses on interactions between fermentable substrates (e.g., starch, fiber, and protein) and selected minerals on nutrient digestion and absorption to determine nutritional solutions to maximize animal performance, principally in the grower-finisher phase, with the aim of minimizing environmental pollution. For phosphorus (P), myo-inositol 1,2,3,4,5,6-hexakis (dihydrogen phosphate) (InsP6), copper (Cu), and zinc (Zn), no standardized methodologies to assess in vitro mineral digestion exist. The stepwise degradation of InsP6 to lower inositol phosphate (InsP) forms in the GIT is rare, and inositol phosphate4 (InsP4) might be the limiting isomer of InsP degradation in diets with exogenous phytase. Furthermore, dietary coefficients of standardized total tract digestibility (CSTTD) of P might be underestimated in diets with fermentable ingredients because of increased diet-specific endogenous P losses (EPL), and further clarification is required to better calculate the coefficients of true total tract digestibility (CTTTD) of P. The quantification of fiber type, composition of fiber fractions, their influence on digestion kinetics, effects on digesta pH, and nutrient solubility related to fermentation should be considered for formulating diets. In conclusion, applications of nutrient kinetic data should be considered to help enhance nutrient digestion and absorption in the GIT, thereby reducing nutrient excretion.